1. Home
  2. |Insights
  3. |ACI’s 28th Annual Drug & Medical Device Litigation Conference

ACI’s 28th Annual Drug & Medical Device Litigation Conference

Event | 12.05.23, 2:00 PM EST

Address

NY Marriott Marquis
1535 Broadway, New York, NY 10036

Register Here

On December 5, Andrew Kaplan will speak at ACI’s 28th Annual Drug & Medical Device Litigation Conference on the panel, "Key Takeaways from this Year’s Top MDLs: Impactful Rulings and Hot Opinions from the Tylenol, Zantac and Exactech MDLs.” This program will analyze the nuances of these three MDLs and provide insights on how developments in recent OTC MDLs may impact the future of prescription pharmaceuticals.

For more information, please visit these areas: Mass Tort, Product, and Consumer Litigation

Participants

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures. 

View All Insights